Home » Topics » BioWorld Science

BioWorld Science
RSS

DuPont Merck describes bisnaphthalimide anticancer drugs

Oct. 11, 1996

ProScript licenses rights to inhibitors of Ras processing

Oct. 11, 1996

Merck describes natural inhibitors of Ras farnesylation

Oct. 11, 1996

Farnesyltransferase inhibitors discovered by RPR

Oct. 11, 1996

Ovarian cancer vaccine enters phase II/III trials

Oct. 11, 1996

New company focuses on small molecules that mimic binding regions of Ig proteins

Oct. 11, 1996

Patent coverage for The Immune Response Corporation's colon cancer vaccine

Oct. 11, 1996

Chemokine polypeptide from Human Genome Sciences has multiple potential uses

Oct. 11, 1996

Antineoplastic aromatase inhibitor from Yamanouchi shows potential for hormone-related illnesses

Oct. 11, 1996

Endorecherche claims EM-800 for estrogen-dependent disorders

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...